Lower limb amputation rates among Medicare beneficiaries with diabetic foot ulcers managed with and without native collagen matrix plus PHMB antimicrobial.
This study looked at whether a specific wound dressing—native collagen matrix with PHMB antimicrobial—helps prevent leg amputations in people with diabetic foot ulcers. The researchers analyzed Medicare data from 2015 to 2023, comparing over 10,000 patients who used this dressing with matched patients who did not. They found that patients using the dressing had lower amputation rates within six months, even though they initially had more severe ulcers. Specifically, the amputation rate was 2.7% in the dressing group versus 4.3% in the comparison group, a significant reduction. This suggests that using this advanced dressing may help preserve limbs in high-risk patients. However, the study was observational, so it cannot prove cause and effect, and it only looked at Medicare beneficiaries in the US, so results may not apply globally.
Key takeaways
- A new study found that a collagen matrix with antimicrobial reduced six-month amputation rates in diabetic foot ulcer patients from 4.3% to 2.7%.
- The study included over 10,000 matched Medicare beneficiaries, making it one of the largest real-world analyses on this dressing.
- Patients who used the dressing had more severe ulcers initially, yet still had fewer amputations, suggesting it may help high-risk cases.
- If you have a diabetic foot ulcer, ask your doctor if this type of advanced dressing is appropriate for your wound.
- The treatment is not a cure, but it may be a valuable addition to standard care to help save limbs.
- Discuss with your healthcare team about access to collagen-based dressings, as availability varies by region and clinic.
Editor's note
In China, diabetic foot ulcer care is evolving, with specialized centers increasingly adopting advanced wound care products. This study's findings support the use of collagen matrix with antimicrobial properties as an adjunct to standard treatment. While the product may not be widely available in all hospitals, it is worth discussing with your doctor, especially in major DFU centers.